Skip to main content

Peer Review reports

From: A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial

Original Submission
8 Nov 2023 Submitted Original manuscript
8 Dec 2023 Author responded Author comments - Susan C. Short
Resubmission - Version 2
8 Dec 2023 Submitted Manuscript version 2
15 Dec 2023 Author responded Author comments - Susan C. Short
Resubmission - Version 3
15 Dec 2023 Submitted Manuscript version 3
18 Dec 2023 Author responded Author comments - Susan C. Short
Resubmission - Version 4
18 Dec 2023 Submitted Manuscript version 4
20 Dec 2023 Author responded Author comments - Susan C. Short
Resubmission - Version 5
20 Dec 2023 Submitted Manuscript version 5
Publishing
22 Dec 2023 Editorially accepted
15 Jan 2024 Article published 10.1186/s12885-023-11792-4

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us